All In Biotech

Drug Trial Radar · NCT07752979

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

A Phase 2 Dose-Finding Study to Assess the Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

360

Planned (sponsor's estimate)

Start

Aug 4, 2026

Primary completion

Mar 2028

Study completion Mar 2028

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Aug 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Obesity is a condition where a person has excessive body fat, defined by a body mass index (BMI) of 30 kg/m2 or higher. The goal of this study is to evaluate the effect of various doses of ABBV-295 compared to placebo on reducing body weight at Week 32 in participants with obesity or overweight with weight-related comorbidities. ABBV-295 is an investigational long-acting amylin analog being developed for chronic weight management. Participants are placed into multiple treatment groups with different dosing paradigms of ABBV-295 or placebo. Participants will not know which treatment they are receiving, and there is a chance of being assigned to placebo. Adults with obesity or overweight (as defined by BMI) with weight-related comorbidities will be enrolled. Approximately 360 participants will be enrolled in the study at approximately 70 sites in the United States and Puerto Rico. Participants will receive subcutaneous (SC) injections of ABBV-295 solution for injection or matching placebo administered via pre-filled syringes for 52 weeks during the Double-Blind Period. There may be higher treatment burden for participants in this trial compared to their standard of care due to study procedures. Participants will attend regular visits during the study at a hospital or clinic. The effects of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Conditions

  • Obesity
  • Overweight

Interventions

  • ABBV-295Drug

    Subcutaneous

  • PlaceboDrug

    Subcutaneous

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline in Body WeightTime frame: Baseline (Week 0) to Week 32
  2. Number of Participants with Adverse Events (AEs)Time frame: Up to approximately week 52

Locations

64 sites in 2 countries. Site status is shown where the registry gives one.

  • Cahaba Research - Pelham /ID# 282381

    Pelham, Alabama · Recruiting

  • Headlands Research - Scottsdale /ID# 282571

    Scottsdale, Arizona · Recruiting

  • Arizona Clinical Trials /ID# 282372

    Tucson, Arizona · Recruiting

  • John Muir Health - Concord /ID# 282469

    Concord, California · Recruiting

  • Aurora FDRC Inc. /ID# 282494

    Costa Mesa, California · Recruiting

  • NorCal Medical Research /ID# 283117

    Greenbrae, California · Recruiting

  • Velocity Clinical Research - Huntington Park /ID# 282987

    Huntington Park, California · Recruiting

  • Los Angeles Institute for Metabolic Research /ID# 282059

    Los Angeles, California · Recruiting

  • Peninsula Research Associates /ID# 282158

    Rolling Hills Estates, California · Recruiting

  • Southern California Dermatology /ID# 282011

    Santa Ana, California · Recruiting

  • Encompass Clinical Research /ID# 282483

    Spring Valley, California · Recruiting

  • University Clinical Investigators /ID# 282132

    Tustin, California · Recruiting

  • Diablo Clinical Research /ID# 282530

    Walnut Creek, California · Recruiting

  • Innovative Research of West Florida /ID# 281963

    Clearwater, Florida · Recruiting

  • Northeast Research Institute (NERI) /ID# 282015

    Fleming Island, Florida · Recruiting

  • Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740

    Jacksonville, Florida · Recruiting

  • Altus Clinical Research - Lake Worth - South Congress Avenue /ID# 281979

    Lake Worth, Florida · Recruiting

  • South Florida Wellness & Clinic /ID# 282022

    Margate, Florida · Recruiting

  • South Broward Research /ID# 282125

    Miramar, Florida · Recruiting

  • Suncoast Clinical Research Pasco County /ID# 282412

    New Port Richey, Florida · Recruiting

  • Charter Research - Winter Park /ID# 281968

    Orlando, Florida · Recruiting

  • Florida Institute For Clinical Research /ID# 282739

    Orlando, Florida · Recruiting

  • Progressive Medical Research /ID# 282838

    Port Orange, Florida · Recruiting

  • Charter Research - The Villages /ID# 282376

    The Villages, Florida · Recruiting

  • Metabolic Research Institute /ID# 282350

    West Palm Beach, Florida · Recruiting

  • Encore Medical Research - Weston /ID# 282044

    Weston, Florida · Recruiting

  • Endocrine Research Solutions /ID# 282020

    Roswell, Georgia · Recruiting

  • Elite Clinical Trials - Blackfoot /ID# 282042

    Blackfoot, Idaho · Recruiting

  • Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378

    Chicago, Illinois · Recruiting

  • L-MARC Research Center /ID# 282008

    Louisville, Kentucky · Recruiting

  • Prime Health and Wellness /ID# 282254

    Fayette, Mississippi · Recruiting

  • Studymetrix Research /ID# 282163

    City of Saint Peters, Missouri · Recruiting

  • Mercury Street Medical /ID# 282016

    Butte, Montana · Recruiting

  • Vector Clinical Trials /ID# 282265

    Las Vegas, Nevada · Recruiting

  • Rochester Clinical Research /ID# 282484

    Rochester, New York · Recruiting

  • Medication Management /ID# 281965

    Greensboro, North Carolina · Recruiting

  • Monroe Biomedical Research /ID# 282009

    Monroe, North Carolina · Recruiting

  • Centricity Research - Morehead city /ID# 283264

    Morehead City, North Carolina · Recruiting

  • Lucas Research - New Bern /ID# 282747

    New Bern, North Carolina · Recruiting

  • Accellacare - Tradd Court - Wilmington /ID# 282200

    Wilmington, North Carolina · Recruiting

Showing 40 of 64 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.